Background: Although the pure-tone average (PTA) remains the standard assessment of hearing status, its results are questionable in the difficult-to-test geriatric population. In this study, we assessed the relationship between the 4-frequency PTA, speech reception threshold (SRT) and auditory brainstem response (ABR) threshold in the aged. We developed an equation as a tool to predict the actual PTA. Methods: Forty-six subjects more than 60 years of age were consecutively enrolled in the study. All subjects underwent hearing threshold evaluation by means of PTA, SRT and ABR testing on both ears. Using simple linear and multiple regressions, the correlation and multiple regression models between PTA, SRT and ABR thresholds were calculated. Results: The Pearson correlation coefficient between pure-tone thresholds (PTTs) and SRT was highest at 0.5–2 kHz (r = 0.948). The Pearson correlation coefficient between PTTs and ABR thresholds was highest at 2–4 kHz (r = 0.690). The resultant multiple regression model to predict actual PTA was: PTA = 3.274 + 0.774 (SRT) + 0.245 (ABR). Conclusions: In this study, we delineated the relationship between the PTA, SRT and ABR threshold, and established an equation to predict the actual PTA from the SRT and ABR threshold in difficult-to-test patients, allowing accurate assessment of the hearing threshold in geriatric populations.
This study established the agreement between Mandarin SRTs and PTTs in the low tone area of speech frequencies in the geriatric population. In clinical settings, SRT test can be rapidly and easily performed and is relatively inexpensive. It is a vital indicator of the accuracy of PTT measurement.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.